Skip to Content
 

News: March, 2019

Correctly copying DNA

Friday, March 15th, 2019

A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.

VUMC Mourns the Passing of Howard W. Jones III, MD

Friday, March 15th, 2019

Howard W. Jones III, MD, professor of Obstetrics and Gynecology, former chair of the department and a world-renowned researcher into the causes and treatment of gynecologic cancer, died unexpectedly in his sleep on Saturday, March 9. He was 76.

Cancer Center Ambassadors surpass $1 million in grants

Friday, March 15th, 2019

Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.

Vanderbilt mourns cancer researcher Stephen Hann

Friday, March 15th, 2019

Stephen Hann, PhD, professor of Cell and Developmental Biology, died Feb. 27. He was 67.

Symposium explores prevention of HPV-associated cancers

Friday, March 15th, 2019

Physicians and researchers from across the country came to the Vanderbilt Symposium on HPV Infections and Associated Cancers on March 1 to discuss screening and prevention strategies for the human papillomavirus (HPV).

Achilles’ heel for kidney cancer

Monday, March 4th, 2019

A recent study found that renal cell carcinoma cells with mutations in an enzyme-encoding gene, SETD2, were sensitive to a drug that inhibits the enzyme PI3K-beta.

Lighting up colorectal cancer

Monday, March 4th, 2019

Wellington Pham, PhD, and colleagues in Japan, have developed a nanobeacon imaging agent to aid the early detection of colorectal cancer during colonoscopy.

Protein loss promotes cell migration

Monday, March 4th, 2019

The protein STK17A (serine threonine kinase 17A) appears to play roles in various cancer types. Researchers have found that cells without STK17A become less connected and more invasive.

Investigators map genomic landscape of very rare cancer

Monday, March 4th, 2019

Vanderbilt researchers have mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

VICC launches new telehealth program for CAR-T patients

Monday, March 4th, 2019

Some cancer patients receiving CAR-T infusions can now avoid hospital stays because of a telemedicine program launched by Vanderbilt-Ingram Cancer Center.

Next Page »